Mode
Text Size
Log in / Sign up
N/A N=10 Treatment

Ultra-high Frequency (500 KHz) Spinal Cord Stimulation for Treatment of Chronic Back Pain or Lower Limb Pain

Pain, Chronic · Pain, Back · Pain, Radiating

Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Oct 2021
Primary outcome: Primary: Change in Visual Analog Score From Baseline to Day 14 — -5.1 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
GiMer Medical MN 1000 External Stimulator (Device)
Age
Adult, Older Adult · 20+ yrs
Sex
All
Sponsor
GiMer Medical
Primary completion
Oct 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Visual Analog Score From Baseline to Day 14
-5.1
PRIMARY
Record Incidence of Adverse Events
16
SECONDARY
The Brief Pain Inventory (BPI)
SECONDARY
Incidence of Stimulation-induced Paresthesia
SECONDARY
Pain Relief Medication Consumption
SECONDARY
Oswestry Low Back Pain Disability Questionnaire (ODI)

Summary

This study is a prospective, single-arm, open label, single center to confirm the effectiveness and safety of an ultra-high frequency (500 KHz) spinal cord stimulation in patients with chronic back pain or lower limb pain.

Eligibility Criteria

Inclusion Criteria

  • Age ≧20 and ≦75
  • Have a symptom of back or lower limb pain with a diagnosis related to spinal lesion, herniated disc, nerve injury, stenosis, failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS) or ischemic lower limb pain and have pain history of >6 months.
  • Have an average pain score >5 by Visual Analogue Scale (VAS) on inclusion.
  • Has failed to achieve adequate pain relief from prior pharmacologic treatments.
  • In the judgement of the investigator, the subject is an appropriate candidate for the trial procedure.
  • The subject is willing and able to comply with the procedure and requirements of this trial.
  • The participant is able to understand and provide informed consent, and has signed their written informed consent in accordance with Institutional Review Board (IRB) requirements.

Exclusion Criteria

  • Have evidence of a mental or psychological condition that affects pain perception and has difficulty/disability performing objective pain assessment, or have previously failed mental or psychological assessments administered by a psychiatrist that may be deemed to indicate the subject's lack of suitability for participation in this study.
  • Subject has exhibited unstable pain condition within the past 30 days as interviewed by Investigator.
  • Be on anticoagulant medication with International Normalized Ratio (INR) >1.5 or platelet count less than 100,000/μL, peripheral vascular diseases (PVDs), visceral pain or uncontrolled Diabetes mellitus (DM).
  • Has had corticosteroid therapy at an intended site of stimulation within the past 30 days.
  • Pain medication(s) dosages(s) are not stable for at least 30 days at investigator's discretion.
  • Currently has an active implantable device including International Classification of Diseases (ICD), pacemaker, spinal cord stimulator or intrathecal drug pump or subject requires magnetic resonance imaging (MRIs) or diathermy.
  • Have a current diagnosis of cancer with active symptoms.
  • Have a known terminal illness with life expectancy less than one year.
  • Have a systematic or local infection, which may increase study risk.
  • Currently has an indwelling device that may pose an increased risk of infection.
  • Be pregnant or breast feeding.
  • Have a medical history of drug or alcohol addiction within the past 2 years.
  • Participation in any investigational study in the last 30 days or current enrollment in any trial.
  • Be currently involved in an injury claim law suit or medically related litigation, including workers compensation.
  • Be a prisoner.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03543085). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search